Monday October 22, 2018 10:50
Food and Healthcare Press Releases
Menarini Ricerche announced today the initiation of the B-PRECISE-01 clinical trial, a multicenter phase Ib study that will evaluate the safety and efficacy of MEN1611 plus trastuzumab with or without fulvestrant. The study will enroll patients with
Osteoporosis, a disease which causes bones to become weak and fragile, is the cause of broken bones in approximately one in three women and one in five men aged over 50 worldwide. (Photo: https://mma.prnewswire.com/media/767079/IOF_Infographic.jpg
- Expansion of the pharma manufacturing site at Merck's headquarters supports growth of current and future portfolio of pharma medicines - New building dedicated to the packaging and shipping of Merck's pharma medicines in more than 90 countries - EUR63
As a company whose purpose is to make the world healthier and happier, premier global nutrition company, Herbalife Nutrition, today released findings from its 2018 Asia Pacific Healthy Aging Survey. Conducted in August 2018 with 5,500 respondents aged 40
- Merck-sponsored survey developed in collaboration with IACO and Eurocarers reveals lifelong effects of caring for a loved one with MS - #MSInsideOut documentary film, executively produced by Shift.ms, provides artistic take on the experiences of those
Expands on existing commercial and co-development agreement for delafloxacin Consolidates company's strategic focus on infectious diseasesThe Menarini Group, an Italian biopharmaceutical company present in 136 countries worldwide, and Melinta
According to Samitivej Allergy Institute, the number of Thais at risk from food allergies has surged by 300-400 percent in recent years as a result of lifestyle changes. The risk factors come from good living and more awareness of cleanliness, which have
Doctor's Talk: Tips to Recover from Training and Competition Like a Pro Athlete By Dr. Korakod Panich (M.D.), Herbalife Nutrition Advisory Board (NAB) Member Have you ever felt that you have been exercising forever without getting anywhere near your
The healthcare robotics company Exosystems will soon be conducting a trial run of its ICT muscular rehabilitation solution "ExoRehab" at hospitals in Vietnam. Exosystems, a member company of the K-ICT Born2Global Centre, has signed a partnership
Doctors at Qatar's first specialist women's and children's hospital Sidra Medicine have successfully separated conjoined twins, marking a first for the country. The surgery establishes an alternative for patients who previously had limited choices for
Herbalife Nutrition, a premier global nutrition company, is launching a social media campaign to promote a healthier and happier life. Health enthusiasts can benefit from 30 innovative nutrition ideas, tips, recipes, games and more, for overall
Qatar Biomedical Research Institute (QBRI), a premier research institute under Hamad Bin Khalifa University (HBKU), has signed a collaborative research and training agreement with the Harvard Stem Cell Institute (HSCI) in Boston, USA. The five-year
Avelumab: LBA6_PR, 659P, 1290P, 1291P, 1282P, 877P; M7824 (TGF β-trap/anti-PD-L1):1048O, 1463P, 1931P, 757P, 643P, 642P, 661P; tepotinib (MET kinase inhibitor): 1377O, 621PD, 698P; M6620: 1437P; M3814: 1845P; M7583: 1014PD; abituzumab: 487P;
As the eighth session of the Conference of the Parties (COP8) to the World Health Organization (WHO) Framework Convention on Tobacco Control (FCTC) just closed in Geneva, new research commissioned by JTI and conducted in Europe by Populus with Ipsos as
Med X Change, Inc, (CEO: Seth Kardos) today announced the launch and Production availability* of the 4Klear, a 4K Camera & Medical Video Recorder All-In-One Solution for surgical microscopes (i.e. Leica Microsystems, Carl Zeiss Meditec, Haag-Streit
- New collaboration center to provide support from pre-clinical through full-scale production in a non-GMP environment - Hands-on customer access to Merck's product portfolio, technical expertise Merck, the vibrant science and technology company, today
Veloce BioPharma Announces Positive Phase 2b Study Results for VBP-926 (Topical Povidone-Iodine in a Novel Non-Aqueous Vehicle) in Subjects with Chemotherapy-Associated Paronychia - Veloce BioPharma's VBP-926 (Povidone-Iodine) Demonstrates Statistically
When treated with once-daily Ryzodeg(R), people with type 2 diabetes achieved similar blood sugar control with half the number of daily injections, significantly lower total daily insulin dose and significantly reduced risk of nocturnal hypoglycaemia in
According to results of a post-hoc analysis people with both type 1 and type 2 diabetes in clinical practice may achieve improved glycaemic control (HbA1c) with Tresiba(R) (insulin degludec) versus insulin glargine U100, without an increase in
New research shows healthcare services and public health strategies aimed at reducing the burden of type 2 diabetes may prove ineffective, unless they address social and cultural factors.[1] Researchers linked factors such as food traditions and
Assistant Administrator of Beijing Zhen-Guo Integrative Medicine Tumor Rehab Hospital (Beijing) 2) รศ.นพ.นรินทร์ วรวุฒิ อายุรศาสตร์มะเร็งวิทยา ประจำโรงพยาบาลชั้นนำหลายแห่ง สอบถามรายละเอียด / สำรองที่นั่ง Tel. 02-664-0079, Facebook :
Samitivej showcases dimensions of excellence with the latest achievement as a winner of The Most Improved Hospital in Thailand Award from the Asian Hospital Management Awards (AHMA). The hospital group is moving forward with a vision of "Organization of
The HIMSS AsiaPac18 Conference and Exhibition will feature HIMSS' first-ever International Military Health Information Technology (IMHIT) track on 7 November. "HIMSS has received tremendous support from global militaries that are embarking on their
Owen Mumford, global industry leader in medical device design and manufacturing, has announced the appointment of Shirley Loh as Regional Managing Director for Asia-Pacific based at the company's Malaysian hub in Nusajaya. (Photo: